Drug-pricing dispute at US Supreme Court raises trade secret disclosure questions
The US Supreme Court on Monday asked the federal government to weigh in on a challenge to Oregon’s drug-pricing transparency law in a case presenting broader questions about constitutional limits on...To view the full article, register now.
Already a subscriber? Click here to view full article